In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we’re speaking about how to best determine the efficacy of regulatory and quality team members. A variety of real-world examples are provided that demonstrate the need to “trust but verify” the actions of these team members. During this conversation, the following questions are addressed:

• Why the need to measure the safety and efficacy of the regulatory and quality team?
• What can happen if you put too much trust or reliance on your regulatory consultant?
• Can you give a specific example where there was too much trust?
• Can you give us another regulatory example, perhaps involving clinical trials?
• Can you provide a quality or manufacturing example, perhaps involving AI?
• What are today’s takeaways?

Listen to this discussion and see if you need a plan to verify your regulatory and quality team members’ actions. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at [email protected], and we’ll see if your ideas/inquiries/suggestions align with a future episode.

Send us Fan Mail

For more medtech news and information, visit https://www.mpomag.com.